HALEOSLABS1,450.00

HALEOS LABS LIMITED

· Pharma & Health
AnnualQuarterly₹ CrorePeersALBERTDAVDVALIANTLABMEDICOMEDICAMEQZIMLABAAREYDRUGSNECLIFEANUHPHRMcap ₹438 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations306.0344.7333.8324.2
Other Income3.84.92.43.1
Total Income309.8349.6336.2327.3
Expenses
+ Cost of Materials Consumed150.2149.9146.7160.6
+ Purchases of Stock-in-Trade0.00.00.0-13.7
+ Changes in Inventories1.04.2-8.2-14.9
+ Employee Benefit Expense49.359.565.466.6
+ Finance Costs10.28.76.46.5
+ Depreciation & Amortisation14.915.015.515.9
+ Other Expenses74.486.185.284.7
Total Expenses299.9323.4311.0305.7
EBITDA31.145.044.740.9
EBIT16.230.029.225.0
Profit
PBT before Exceptional Items9.826.225.221.6
Pretax Income9.826.225.221.6
+ Current Tax4.19.05.54.6
+ Deferred Tax-0.5-1.51.91.8
Tax Expense3.57.57.46.4
Net Income6.318.717.815.3
+ Net Income — Continuing Ops6.318.717.815.3
+ Other Comprehensive Income-0.50.10.10.2
Total Comprehensive Income5.918.917.915.4
Net Income to Common9.120.117.315.8
Minority Interest-2.8-1.40.5-0.5
Per Share
Basic EPS30.0866.5157.2652.27
Diluted EPS30.0866.5157.2652.27
Other Comprehensive Income — detail
+ Other Comprehensive Income0.10.10.2
+ Tax on Items NOT to be Reclassified-0.2-0.2-0.2
+ Tax on Items NOT to be Reclassified — alt tag0.6
+ Tax on Items to be Reclassified0.00.00.1
+ Tax on Items to be Reclassified — alt tag-0.2
Comprehensive Income — Owners of Parent8.720.217.415.9
Comprehensive Income — Non-controlling Interests-2.9-1.30.5-0.5
Per Share — as-filed variants
Basic EPS — Continuing Operations30.0866.5157.2652.27
Diluted EPS — Continuing Operations30.0866.5157.2652.27
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit154.8190.7195.3192.3
Gross Margin %50.5955.3158.5059.30
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)9.826.225.221.6
Net Income Adj (tax-effected)6.318.717.815.3
EPS Adj30.0866.5157.2652.27
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital3.03.03.03.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.